Search

everythinglearnresearchcommunity

for

Search:↓

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Oral ritlecitinib and baricitinib are promising treatments for severe alopecia areata due to their balance of effectiveness and safety.

Ritlecitinib is generally safe for long-term use, with mostly mild side effects.

Two compounds from Asiasarum heterotropoides roots show potential as lung cancer treatments without harming normal cells.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Baricitinib helps treat severe hair loss in people over 65.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Tamsulosin for enlarged prostate may increase the risk of severe low blood pressure, especially when starting or restarting the medication.

Dutasteride is linked to a higher chance of sexual dysfunction, especially in younger males and the elderly.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Dutasteride effectively treats enlarged prostate with manageable side effects.

Endovascular repair and open surgery for abdominal aortic aneurysms both result in a temporary decline in physical health, with no significant mental health difference, and a return to near normal health in 90 days.

A heterozygous mutation in HTRA1 can cause severe CARASIL symptoms.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Taking five small dutasteride capsules is the same as taking one larger capsule.

5-alpha reductase inhibitors, like finasteride and dutasteride, are used for prostate issues, hair loss, and excessive hair growth, may help with COVID-19, but can cause sexual and mental health side effects, and their use in preventing prostate cancer needs more examination.

Both treatments for alopecia areata showed similar modest effectiveness.

Aumolertinib is effective and well-tolerated for treating advanced lung cancer with EGFR mutations.

Ursolic acid can shrink the prostate and lower a hormone linked to prostate growth in rats.

Etrasimod is safe but not effective for severe alopecia areata, though it may help milder cases.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Saw palmetto may improve urinary symptoms with fewer sexual side effects compared to some medications.

Adding Baricitinib for severe alopecia areata will have a small impact on a health plan's budget.

GSK-36 downregulation with UTMD improves plaque stability in atherosclerosis treatment.

Breadfruit is nutritious and has potential health and medicinal benefits, but is currently underused.

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

PDE5 inhibitors cause earlier adverse events in BPH treatment, requiring careful monitoring.

JAK inhibitors show promise for treating alopecia areata but have serious side effects.